Phosphonic Acid

Phosphonic Acid

SCHEMBL15510587

Br.O=[PH](O)O.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Phosphonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.63
CYP3A4 P08684 1/20 0.63
ESR1 P03372 4/20 0.54
ESR2 Q92731 4/20 0.54
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
CES2 O00748 3/20 0.33
CES1 P23141 3/20 0.33
CA2 P00918 2/20 0.33
CA4 P22748 2/20 0.33
ALDH1A1 P00352 2/20 0.32
DAO P14920 1/20 0.32
TSHR P16473 1/20 0.32
NAPRT Q6XQN6 1/20 0.32
ALOX15 P16050 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
CA12 O43570 1/20 0.30
CA1 P00915 1/20 0.30
GLA P06280 1/20 0.30
CA3 P07451 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphonic Acid SCHEMBL15510586 1.00 TDP1 (0.63) TDP1CYP3A4ESR1ESR2KDM4E
Phosphonic Acid SCHEMBL7871109 0.97 TDP1 (0.67) TDP1CYP3A4ESR1ESR2KDM4E
Phosphonic Acid SCHEMBL15511192 0.95 TDP1 (0.63) TDP1CYP3A4ESR1ESR2KDM4E
Phosphonic Acid SCHEMBL15511191 0.95 TDP1 (0.63) TDP1CYP3A4ESR1ESR2KDM4E
Phosphonic Acid SCHEMBL28820202 0.92 CYP3A4 (0.60) TDP1CYP3A4ESR1ESR2KDM4E
Acetic Acid SCHEMBL15511068 0.88 CYP3A4 (0.55) TDP1CYP3A4ESR1ESR2KDM4E
Phosphonic Acid SCHEMBL15511198 0.88 TDP1 (0.55) TDP1CYP3A4ESR1ESR2KDM4E
Sulfuric Acid SCHEMBL15511079 0.88 TDP1 (0.55) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL4944650 0.87 CYP3A4 (0.60) TDP1CYP3A4ESR1ESR2KDM4E
Phosphonic Acid SCHEMBL15572106 0.85 CYP3A4 (0.57) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104736245-B Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts 米德瑞(美国)有限公司 2017-04-12 CN claimed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US claimed
CN-104736245-A Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts MIDORI RENEWABLES INC 2015-06-24 CN claimed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
EP-4209130-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-12 EP disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 EP disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 US disclosed
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE DSM NUTRITIONAL PRODUCTS, LLC 2022-12-29 US disclosed
US-20220400728-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-12-22 US disclosed
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-11-18 US disclosed
WO-2016122885-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 WO disclosed
WO-2016122887-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 WO disclosed
WO-2016122884-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 WO disclosed
US-9238845-B2 Methods of producing sugars from biomass feedstocks MIDORI USA, INC. (US) 2016-01-19 US disclosed
US-20160007642-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 US disclosed
WO-2016007778-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 WO disclosed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 US disclosed
CN-104736245-A Polymeric and solid-supported catalysts, and methods of digesting cellulosic materials using such catalysts MIDORI RENEWABLES INC 2015-06-24 CN disclosed
US-20140060522-A1 METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS HERCULES CAPITAL, INC. 2014-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC TDP1 4759/4885CYP3A4 4177/4885ESR1 4879/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 TDP1 4531/4885CYP3A4 2269/4885ESR1 4812/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC TDP1 4759/4885CYP3A4 4177/4885ESR1 4879/4885
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS TDP1 4614/4885CYP3A4 4853/4885ESR1 4845/4885
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF OSTC, FUT5, FUT6 TDP1 4665/4885CYP3A4 3782/4885ESR1 4881/4885
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS MGAM, CEL, SI TDP1 920/4885CYP3A4 1469/4885ESR1 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.